| Followers | 28 |
| Posts | 2926 |
| Boards Moderated | 0 |
| Alias Born | 11/15/2021 |
Tuesday, September 02, 2025 1:48:51 PM
In response to your recent post on another board, the reason why I turned you on to this play here was the volatility is here so it would make a good trading and training place to help me out.
I did offer up my email which you used to have to throw me some tips. The 15 minute chart seems to be an important tool. I guess trading between support n resistance seems pretty reliable here.
On another note is there a timeline before Ixhl loses Nasdaq trading? I guess the only benefit is that large investment firms are permitted to trade stocks on Nasdaq but not OTC, although it didn't stop the huge volume previously experienced here.
I did offer up my email which you used to have to throw me some tips. The 15 minute chart seems to be an important tool. I guess trading between support n resistance seems pretty reliable here.
On another note is there a timeline before Ixhl loses Nasdaq trading? I guess the only benefit is that large investment firms are permitted to trade stocks on Nasdaq but not OTC, although it didn't stop the huge volume previously experienced here.
Recent IXHL News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 12:00:44 PM
- Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness • GlobeNewswire Inc. • 04/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 12:00:23 PM
- Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position • GlobeNewswire Inc. • 03/27/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:00:06 PM
- Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research • GlobeNewswire Inc. • 03/25/2026 12:00:00 PM
- Incannex says it holds $75 million in cash with zero debt after financing • IH Market News • 03/18/2026 02:24:59 PM
- Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development • GlobeNewswire Inc. • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 12:00:21 PM
- Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/17/2026 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/12/2026 08:17:41 PM
- Incannex outlines dose-optimization study for sleep apnea treatment • IH Market News • 03/12/2026 03:42:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:05:33 PM
- Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/12/2026 12:05:00 PM
- Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance • IH Market News • 02/25/2026 03:26:23 PM
- Incannex Announces Reverse Stock Split • GlobeNewswire Inc. • 02/25/2026 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 01:00:33 PM
- Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026 • Newsfile • 02/18/2026 11:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 12:48:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 01:04:16 PM
- Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board • GlobeNewswire Inc. • 01/29/2026 01:00:00 PM
- Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program • GlobeNewswire Inc. • 01/22/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 12:30:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 02:57:26 AM
